Conversely, increased expression of NAT10 promoted proliferation and tumorigenicity in both NSCLC cell lines in contrast to the vector group (Figure 3D), corroborating findings from the CCK‐8 assay. The gene discussed is NAT10; the disease is non-small cell lung carcinoma.